메뉴 건너뛰기




Volumn 25, Issue 10, 2006, Pages 1085-1086

Is there a place for activated protein C (Xigris®) in the treatment of severe imported malaria in the adult?;Y a-t-il une place pour la protéine C activée (Xigris®) dans le traitement du paludisme grave d'importation de l'adulte ?

Author keywords

Drotrecogin alpha (activated); Severe imported malaria

Indexed keywords

ANTIPARASITIC AGENT; DROTRECOGIN; NORADRENALIN; QUININE;

EID: 33750328534     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2006.06.011     Document Type: Letter
Times cited : (6)

References (5)
  • 1
    • 0034068284 scopus 로고    scopus 로고
    • Severe falciparum malariae
    • World Health Organisation
    • World Health Organisation. Severe falciparum malariae. Trans. R. Soc. Trop. Med. Hyg. 94 Suppl 1 (2000) 1-90
    • (2000) Trans. R. Soc. Trop. Med. Hyg. , vol.94 , Issue.SUPPL. 1 , pp. 1-90
  • 2
    • 0642307051 scopus 로고    scopus 로고
    • Le paludisme grave en réanimation en 2003
    • Saïssy J.M., Rouvin B., and Koulmann P. Le paludisme grave en réanimation en 2003. Med. Trop. 63 (2003) 258-266
    • (2003) Med. Trop. , vol.63 , pp. 258-266
    • Saïssy, J.M.1    Rouvin, B.2    Koulmann, P.3
  • 3
    • 0035826096 scopus 로고    scopus 로고
    • Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Efficacy and safety of recombinant human activated protein C for severe sepsis
    • Bernard G.R., Vincent J.L., Laterre P.F., LaRosa S.P., Dhainaut J.F., Lopez-Rodriguez A., et al. Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 344 (2001) 699-709
    • (2001) N. Engl. J. Med. , vol.344 , pp. 699-709
    • Bernard, G.R.1    Vincent, J.L.2    Laterre, P.F.3    LaRosa, S.P.4    Dhainaut, J.F.5    Lopez-Rodriguez, A.6
  • 4
    • 0037897393 scopus 로고    scopus 로고
    • Systemic host responses in severe sepsis analysed by causative microorganism and treatment effects of drotrecogin alpha (activated)
    • Opal S.M., Garber G.E., LaRose S.P., Maki D.G., Freebairn R.C., Kinasewitz G.T., et al. Systemic host responses in severe sepsis analysed by causative microorganism and treatment effects of drotrecogin alpha (activated). Clin. Infect. Dis. 37 (2003) 50-58
    • (2003) Clin. Infect. Dis. , vol.37 , pp. 50-58
    • Opal, S.M.1    Garber, G.E.2    LaRose, S.P.3    Maki, D.G.4    Freebairn, R.C.5    Kinasewitz, G.T.6
  • 5
    • 0026710191 scopus 로고
    • Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine
    • Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101 (1992) 1644-1655
    • (1992) Chest , vol.101 , pp. 1644-1655
    • Bone, R.C.1    Balk, R.A.2    Cerra, F.B.3    Dellinger, R.P.4    Fein, A.M.5    Knaus, W.A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.